Abstract
Keywords
Bevacizumab (74)Cetuximab (70)Clopidogrel (61)Cytosine Arabinoside* (67)Doxorubicin (74)Fatal ADRs (62)Gadolinium Contrast Agents (69)Gefitinib (68)Hydroxychloroquine* (63)Methadone (71)Strontium Ranelate* (65)Terazosin* (72)Terbinafine (64)Tramadol (73)Venlafaxine (64)Voriconazole (64)Zonisamide* (66)
Get full access to this article
View all access options for this article.